Dendrimer for therapy and imaging
AssigneeStarpharma Pty Limited
InventorsDavid James OWEN, Richard HUFTON, Kristofer James THURECHT
Life of this patent
Estimating the term…
Loading patent…
AssigneeStarpharma Pty Limited
InventorsDavid James OWEN, Richard HUFTON, Kristofer James THURECHT
Estimating the term…
Provided herein is a dendrimer comprising: i) a core unit (C); and ii) building units (BU), wherein the core unit is covalently attached to at least two building units; the dendrimer having from two to six generations of building units; wherein building units of different generations are covalently attached to one another; and the dendrimer further comprising: iii) one or more first terminal groups attached to an outermost building unit, wherein each first terminal group comprises a radionuclide-containing moiety; and iv) one or more second terminal groups attached to an outermost building unit, wherein each second terminal group comprises a pharmacokinetic-modifying moiety; or a salt thereof. Also provided are compositions comprising the dendrimers, and methods of using the dendrimers and compositions in diagnostic and therapeutic applications.
A dendrimer comprising:
An intermediate for producing a radionuclide-containing dendrimer which comprises:
Dependencies are inferred from the claim text.